NeuroPace, Inc.
NPCE
$10.79
$0.363.45%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -5.25M | -5.45M | -7.51M | -8.93M | -6.20M |
| Total Depreciation and Amortization | 451.00K | 451.00K | 444.00K | 423.00K | 409.00K |
| Total Amortization of Deferred Charges | 49.00K | 47.00K | 54.00K | 78.00K | 76.00K |
| Total Other Non-Cash Items | 2.96M | 2.68M | 3.47M | 3.54M | 3.17M |
| Change in Net Operating Assets | -3.00M | 548.00K | -352.00K | -2.65M | -795.00K |
| Cash from Operations | -4.80M | -1.72M | -3.90M | -7.53M | -3.34M |
| Capital Expenditure | -39.00K | -100.00K | -63.00K | -104.00K | -32.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.00M | 1.50M | 3.30M | 2.50M | 3.50M |
| Cash from Investing | 1.96M | 1.40M | 3.24M | 2.40M | 3.47M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 940.00K | 2.97M | 581.00K | 721.00K | 8.44M |
| Repurchase of Common Stock | -92.00K | -68.00K | -72.00K | -649.00K | -37.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -186.00K |
| Cash from Financing | 848.00K | 2.90M | 509.00K | 72.00K | 8.21M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.99M | 2.57M | -154.00K | -5.06M | 8.34M |